Indian Pediatrics

, Volume 47, Issue 12, pp 1005–1010 | Cite as

Understanding refusal and abandonment in the treatment of childhood cancer

  • Ramandeep Singh AroraEmail author
  • B. Pizer
  • T. Eden


Treatment refusal and abandonment is the principal cause of therapy failure in children with cancer in the developing world. A complex interplay of biological, socio-economic and treatment-related factors underlies this problem. Interventions are likely to succeed when they try and address all of these issues simultaneously, as exemplified by the success of twinning programs linking resource-rich and resource-limited countries. Hitherto, there has been no systematic attempt to understand and address this problem in India. Based on the knowledge gained from research in other parts of the developing world, we offer suggestions for dealing with this problem.

Key words

Childhood cancer Treatment refusal Treatment abandonment Developing countries India 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Stiller C, ed. Childhood Cancer in Britain: Incidence Survival, Mortality. Oxford: Oxford University Press; 2007.Google Scholar
  2. 2.
    Howard SC, Pedrosa M, Lins M, Pedrosa A, Pui CH, Ribeiro RC, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004;291:2471–2475.PubMedCrossRefGoogle Scholar
  3. 3.
    Kellie SJ, Howard SC. Global child health priorities: what role for paediatric oncologists? Eur J Cancer 2008;44:2388–2396.PubMedCrossRefGoogle Scholar
  4. 4.
    Metzger ML, Howard SC, Fu LC, Peña A, Stefan R, Hancock ML, et al. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries. Lancet 2 2003;362:706–708.CrossRefGoogle Scholar
  5. 5.
    Mostert S, Sitaresmi MN, Gundy CM, Sutaryo, Veerman AJ. Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia. Pediatrics 2006;118:e1600–1606.PubMedCrossRefGoogle Scholar
  6. 6.
    Kulkarni K, Marwaha RK, Trehan A, Bansal D. Survival outcome in childhood ALL: experience from a tertiary care centre in North India. Pediatr Blood Cancer 2009;53:168–173.PubMedCrossRefGoogle Scholar
  7. 7.
    Arora RS, Eden T, Pizer B. The problem of treatment abandonment in children from developing countries with cancer. Pediatr Blood Cancer 2007;49:941–946.PubMedCrossRefGoogle Scholar
  8. 8.
    Arora RS, Eden T, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer 2009;46:264–273.PubMedCrossRefGoogle Scholar
  9. 9.
    Arora B, Kurkure P, Parikh P. Childhood cancers: perspectives in India. J Indian Med Assoc 2005;103:479–842.PubMedGoogle Scholar
  10. 10.
    Bonilla M, Rossell N, Salaverria C, Gupta S, Barr R, Sala A, et al. Prevalence and predictors of abandonment of therapy among children with cancer in El Salvador. Int J Cancer 2009;125:2144–2146.PubMedCrossRefGoogle Scholar
  11. 11.
    Sitaresmi MN, Mostert S, Schook R, Sutaryo, Veerman AJ. Treatment refusal and abandonment in childhood acute lymphoblastic leukemia in Indonesia: an analysis of causes and consequences. Psycho-oncology 2010;19:361–367.PubMedCrossRefGoogle Scholar
  12. 12.
    Yadav S, Anjan M, Sachdeva A. Outcome of children with haematological malignancies who are lost to follow up [abstract]? Pediatr Blood Cancer 2007;49:527.Google Scholar
  13. 13.
    Borooah VK. Gender bias among children in India in their diet and immunisation against disease. Soc Sci Med 2004;58:1719–1731.PubMedCrossRefGoogle Scholar
  14. 14.
    Pearce MS, Parker L. Childhood cancer registrations in the developing world: still more boys than girls. Int J Cancer 2001;91:402–406.PubMedCrossRefGoogle Scholar
  15. 15.
    Abuidris DO, Elimam ME, Nugud FM, Elgaili EM, Ahmed ME, Arora RS. Wilms tumour in Sudan. Pediatr Blood Cancer 2008;50:1135–1137.PubMedCrossRefGoogle Scholar
  16. 16.
    Yeh CH, Lin CF, Tsai JL, Lai YM, Ku HC. Determinants of parental decisions on ‘drop out’ from cancer treatment for childhood cancer patients. J Adv Nurs 1999;30:193–199.PubMedCrossRefGoogle Scholar
  17. 17.
    Sachdeva A, Jain V, Yadav SP, Gupta S, Pruthi PK, Arya SC. Move to alternative medicine why? and when? the Indian scenario [abstract]. Pediatr Blood Cancer 2005;45:578.Google Scholar
  18. 18.
    Israëls T, Chirambo C, Caron H, de Kraker J, Molyneux E, Reis R. The guardians’ perspective on paediatric cancer treatment in Malawi and factors affecting adherence. Pediatr Blood Cancer 2008;51:639–642.PubMedCrossRefGoogle Scholar
  19. 19.
    Mostert S, Sitaresmi MN, Gundy CM, Sutaryo, Veerman AJ. Parental experiences of childhood leukemia treatment in indonesia. J Pediatr Hematol Oncol 2008;30:738–743.PubMedCrossRefGoogle Scholar
  20. 20.
    Mostert S, Sitaresmi MN, Gundy CM, Sutaryo, Veerman AJ. Attitude of health-care providers toward childhood leukemia patients with different socio-economic status. Pediatr Blood Cancer 2008;50:1001–1005.PubMedCrossRefGoogle Scholar
  21. 21.
    Chandy M. An approach to the management of leukemia in the developing world. Clin Lab Haematol 2006;28:147–153.PubMedCrossRefGoogle Scholar
  22. 22.
    Masera G, Baez F, Biondi A, Cavalli F, Conter V, Flores A, et al. North-South twinning in paediatric haemato-oncology: the La Mascota programme, Nicaragua. Lancet 1998;352:1923–1926.PubMedCrossRefGoogle Scholar
  23. 23.
    Yolanda E, Estela C, Yolanda R, Cesar KJ. Diminishing the abandonment of very poor children through giving them money for transportation and strict controls from health nets, this corresponds to My Child Matters project [abstract]. 8th INCTR Meeting on Cancer in Countries with Limited resources; 2009 Mar 22–24; Antalya, Turkey.Google Scholar
  24. 24.
    Mostert S, Sitaresmi MN, Gundy CM, Sutaryo, Veerman AJ. Does aid reach the poor? Experiences of a childhood leukaemia outreach-programme. Eur J Cancer 2009;45:414–419.PubMedCrossRefGoogle Scholar
  25. 25.
    Mostert S, Sitaresmi MN, Gundy C, Janes V, Sutaryo S, Veerman AJ. Comparing childhood leukemia treatment before and after introduction of parental-education program in Indonesia. Arch Dis Child 2010;95:20–25.PubMedCrossRefGoogle Scholar
  26. 26.
    Wilimas JA, Wilson MW, Haik BG, Barnoya M, Fu L, Castellanos M, et al. Development of retinoblastoma programs in Central America. Pediatr Blood Cancer 2009;53:42–46.PubMedCrossRefGoogle Scholar
  27. 27.
    Hesseling PB, Broadhead R, Molyneux E, Borgstein E, Schneider JW, Louw M, et al. Malawi pilot study of Burkitt lymphoma treatment. Med Pediatr Oncol 2003;41:532–540.PubMedCrossRefGoogle Scholar
  28. 28.
    Hesseling P, Broadhead R, Mansvelt E, Louw M, Wessels G, Borgstein E, et al. The 2000 Burkitt lymphoma trial in Malawi. Pediatr Blood Cancer 2005;44:245–250.PubMedCrossRefGoogle Scholar
  29. 29.
    Chandy M. Childhood acute lymphoblastic leukemia in India: an approach to management in a three-tier society. Med Pediatr Oncol 1995;25:197–203.PubMedCrossRefGoogle Scholar
  30. 30.
    Hunger SP, Sung L, Howard SC. Treatment strategies and regimens of graduated intensity for childhood acute lymphoblastic leukemia in low-income countries: A proposal. Pediatr Blood Cancer 2009;52:559–565.PubMedCrossRefGoogle Scholar

Copyright information

© Indian Academy of Pediatrics 2010

Authors and Affiliations

  1. 1.Cancer Research UK Paediatric and Familial Cancer Research GroupUniversity of ManchesterManchesterUK
  2. 2.Alder Hey Children’s NHS Foundation TrustLiverpoolUK
  3. 3.Teenage and Young Adult Cancer and Faculty Associate Brooks Poverty InstituteUniversity of Manchester, c/o TCT Young Oncology Unit, Christie Hospital NHS Foundation Trust ManchesterManchesterUK
  4. 4.Cancer Research UK Paediatric and Familial Cancer Research GroupRoyal Manchester Children’s HospitalManchesterUK

Personalised recommendations